Rheumatoid factor (RF) levels drop most effectively when the underlying cause is treated directly, whether that’s rheumatoid arthritis, an infection like hepatitis C, or another inflammatory condition. There’s no single supplement or lifestyle change that reliably lowers RF on its own, but a combination of medical treatment, smoking cessation, and certain dietary strategies can move the number in the right direction. Lowering RF matters because higher levels correlate with more active disease, greater joint damage, and worse long-term outcomes.
Why Your RF Level Matters
RF isn’t just a diagnostic checkbox. It tracks with disease activity in real time. When RF exceeds a certain threshold, the risk of active rheumatoid arthritis (measured by standard clinical scores) increases by roughly 60 to 99 percent compared to patients below that threshold. A systematic review also found that RF correlates with bone erosion visible on ultrasound. So bringing RF down isn’t about chasing a lab number for its own sake. Declining RF levels after treatment consistently match declining disease activity, making it a useful marker for whether your treatment is actually working.
For reference, Mayo Clinic Laboratories defines a normal IgM rheumatoid factor as less than 5.0 IU/mL. IgA rheumatoid factor is considered negative below 20 CU. Your lab may use slightly different cutoffs, but these are widely used benchmarks.
Disease-Modifying Medications
The most reliable way to lower RF is through disease-modifying drugs (DMARDs), which target the immune dysfunction that produces rheumatoid factor in the first place. Methotrexate, the most commonly prescribed DMARD, significantly reduces all three major types of RF (IgM, IgA, and IgG) within 6 to 12 months of starting low-dose treatment. It does this by dampening the overactive immune cells responsible for producing these autoantibodies.
The timeline matters and can feel slow. In one large analysis of RF-positive patients starting DMARD therapy, only about 11 percent showed a meaningful RF response at 3 months. By 6 months, that rose to 25.5 percent, and by 12 months, 41 percent had responded. The encouraging finding is that even an early drop at the 3-month mark predicts better clinical outcomes over the following 6 to 24 months. So if your RF starts trending down early, that’s a strong signal your treatment plan is on track.
Biologic medications that block inflammation (like TNF inhibitors) also lower RF indirectly by controlling disease activity. However, very high baseline RF levels, above roughly 200 IU/mL, can actually interfere with how well certain biologics work. Patients with RF above that threshold were 3.6 times more likely to stop responding to treatment over time, and their blood levels of the medication were significantly lower. This means your starting RF level can influence which biologic your doctor recommends.
Quit Smoking
Smoking is one of the strongest modifiable risk factors for developing RF-positive (seropositive) rheumatoid arthritis. Quitting reduces your risk, but the timeline is long. A study following nurses over decades found that compared to recent quitters (less than 5 years), women who had quit 30 or more years ago had a 37 percent lower risk of seropositive RA. Even so, a slightly elevated risk persisted three decades after quitting compared to people who never smoked.
This doesn’t mean quitting is pointless. It means the earlier you quit, the more benefit you gain. Smoking drives RF production by triggering immune changes in the lungs, particularly in people who carry certain genetic risk factors. Removing that trigger won’t erase RF overnight, but sustained cessation is one of the few lifestyle changes with solid long-term evidence behind it.
Omega-3 Fatty Acids
Fish oil supplements show a genuine association with lower RF levels, but with an important caveat: the benefit appears strongest in people who carry a specific genetic marker called the shared epitope, which is present in a large portion of RA patients. In people with this genetic trait, omega-3 supplement use in the prior year was associated with a 68 percent lower prevalence of RF positivity. Higher omega-3 levels in red blood cells showed a similarly strong protective association, with roughly 74 percent lower odds of high-titer RF.
In people without this genetic marker, omega-3s showed no meaningful relationship with RF at all. So fish oil isn’t a universal RF-lowering strategy, but if you have RA or are at genetic risk for it, there’s reasonable evidence that consistent omega-3 intake may help keep RF levels lower. Standard fish oil supplements providing 1 to 3 grams of combined EPA and DHA daily are what most studies use.
Curcumin Supplements
Curcumin, the active compound in turmeric, has shown surprisingly strong effects on RF in clinical trials, though the evidence base is still small. A meta-analysis of placebo-controlled trials found that curcumin significantly lowered RF levels compared to placebo. Both lower doses (250 mg or less) and higher doses reduced RF, with the higher doses showing a somewhat larger effect. Curcumin also improved pain scores, reduced swollen and tender joint counts, and lowered inflammatory markers like CRP.
The catch: only two studies with a combined 60 participants specifically measured RF, and the overall certainty of the evidence was rated low. Curcumin is poorly absorbed on its own, so formulations with added piperine (black pepper extract) or lipid-based delivery are typically used in studies. It’s a promising addition to standard treatment, not a replacement for it.
Treat the Underlying Cause
Elevated RF doesn’t always mean rheumatoid arthritis. Chronic infections are a major and sometimes overlooked cause. Hepatitis C produces elevated RF in up to 76 percent of cases, particularly when it causes a condition called cryoglobulinemia. Tuberculosis and a heart valve infection called subacute infective endocarditis also raise RF levels. Successfully treating these infections frequently causes rheumatoid factor to disappear entirely.
Because of the strong hepatitis C connection, it’s been recommended that anyone with unexplained elevated RF be screened for hepatitis C. If your RF came back positive but you don’t have joint symptoms typical of RA, an underlying infection is worth investigating. Treating the root cause is often the most effective and fastest route to normalization.
What a Realistic Timeline Looks Like
RF levels don’t respond to any intervention quickly. With prescription DMARDs, measurable drops typically begin around 3 months, with more substantial reductions at 6 to 12 months. For smoking cessation, meaningful risk reduction unfolds over years to decades. Supplements like omega-3s and curcumin have been studied over weeks to months, but their effects are modest compared to medications and work best as part of a broader treatment plan.
The practical takeaway: if you’re tracking your RF levels, check them at 3 months after starting or changing treatment. An early decline, even a small one, is a good prognostic sign. If RF hasn’t budged by 6 months, that’s useful information for your doctor when considering whether to adjust your treatment approach.